NL-OMON52433招募中不适用
The effect of different radiotherapy regimen on the immune cell landscape - The effect of radiotherapy on immune cell landscape
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- treated with radiotherapy for cancer at the Radboudumc
- •- understand dutch
- •- mentally competent
- •- 30-80 years old
排除标准
- •- autoimmune disease
- •- immune- suppressive drugs (with the exception of <= 10 mg prednisone or
- •equivalent doses of corticosteroids).
研究者
相似试验
已完成
不适用
Investigation on radiotherapy treatment effect using perfusion and diffusion-weighted MR imagingtumorJPRN-UMIN000014439Kyoto Univerisity Hospital
进行中（未招募）
1 期
Phase III intergroup Study of Radiotherapy versus Temozolomide Alone versus Radiotherapy with concomitant and adjuvant Temozolomide for Patients with 1p/19q Codeleted Anaplastic Glioma. - CodeletedEUCTR2008-007295-14-ATEORTC488
进行中（未招募）
不适用
Phase III intergroup Study of Radiotherapy versus Temozolomide Alone versus Radiotherapy with concomitant and adjuvant Temozolomide for Patients with 1p/19q Codeleted Anaplastic Glioma. - CodeletedEUCTR2008-007295-14-GBEORTC488
进行中（未招募）
1 期
Phase III intergroup Study of Radiotherapy versus TemozolomideAlone versus Radiotherapy with concomitant and adjuvantTemozolomide for Patients with 1p/19q Codeleted AnaplasticGlioma.ewly Diagnosed Anaplastic Glioma with Chromosomal co-deletions of 1p and 19qMedDRA version: 19.0Level: PTClassification code 10002224Term: Anaplastic astrocytomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 19.0Level: LLTClassification code 10027744Term: Mixed astrocytoma-oligodendrogliomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 19.0Level: PTClassification code 10065443Term: Malignant gliomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 19.0Level: PTClassification code 10026659Term: Malignant oligodendrogliomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2008-007295-14-NLEuropean Organization for Research and Treatment of Cancer (EORTC)488
已完成
3 期
Phase III intergroup Study of Radiotherapy versus Temozolomide Alone versus Radiotherapy with concomitant and adjuvant Temozolomide for Patients with 1p/19q Codeleted Anaplastic Glioma.anaplastic oligodendroglial tumors10029211NL-OMON44004European Organisation for Research in Treatment of Cancer (EORTC)54